April 24, 2020 (LifeSiteNews) — Controversy broke out in France at the end of March when a government decree made an anti-epileptic drug — clonazepam, Rivotril in France, known as Klonopin in the U.S. — available outside its specific marketing authorization, in order for it to be used on patients with respiratory distress in the context of the COVID-19 epidemic. Critics say the drug can now be used to kill off the fragile and the elderly. One of the reasons for their fears is that there is a formal contraindication for use of the molecule in case of respiratory distress,...